Cost-Effectiveness Analysis of the Piloting of Malaria Rapid Diagnostic Test kits within Region 8, Guyana

Download Article

DOI: 10.21522/TIJPH.2013.13.04.Art020

Authors : Tatkan G.

Abstract:

The objective of this study was to conduct a Cost-Effectiveness Analysis (CEA) of piloting Rapid Diagnostic Test (RDT) kits in Region 8 of Guyana. The primary aim was to assess whether the introduction of RDTs provided good value for money and whether it could be considered a cost-effective intervention for malaria diagnosis in remote, high-burden areas. A quantitative analysis approach was employed, utilizing secondary data collected from multiple authorized sources, including government agencies such as the Ministry of Health. The data included expenditure records, payment vouchers, project reports, and receipts, providing critical financial information to estimate costs associated with the RDT pilot and microscopy testing. The results revealed that the total cost of implementing the RDT pilot project was USD 67,161, with the majority of expenditures allocated towards human resources. The estimated cost for administering a single RDT was USD 13.23. The findings demonstrated that the community-based approach was more cost-effective because it avoided additional expenses related to the construction and operation of new health facilities and hiring of personnel. By comparison, the cost of microscopy testing was estimated at USD 31.44 per patient, with the principal cost drivers identified as human resource salaries and facility operational expenses. Based on the Incremental Cost-Effectiveness Ratio (ICER) analysis, the intervention was deemed highly cost-effective. When compared to Guyana’s GDP per capita, which was USD 3,883 in 2017 according to the Guyana Bureau of Statistics, the piloting of RDTs was shown to be a financially sustainable and impactful approach to strengthening malaria diagnosis in underserved regions.

References:

[1].   WHO, 2017, World Malaria Report. Geneva: WHO.

[2].   White, M. T., Conteh, L., Cibulskis, R., Ghani, A. C., 2011, Costs and cost-effectiveness of malaria control interventions—a systematic review. Malaria Journal, 10(1):337.

[3].   WHO, 2010, World Malaria Report. Geneva: WHO.

[4].   United Nations, 2015, Transforming our World: The 2030 Agenda for Sustainable Development.

[5].   Guyana Ministry of Health, 2016, Guyana National Malaria Strategic Plan [2016 to 2021].

[6].   Fonseca, A. G., Carvalho, S., Dias, S., Baptista, J. L., Torgal, J., 2016, Understanding the occupational traveller profile towards malaria prevention enables directed health promotion and preventive practices. International Journal of Tropical Medicine and Public Health, 6. 10.5455/211930/ijtmph.

[7].   Ruktanonchai, N. W., DeLeenheer, P., Tatem, A. J., Alegana, V. A., Caughlin, T. T., zu Erbach-Schoenberg, E., Lourenço, C., Ruktanonchai, C. W., Smith, D. L., 2016, Identifying malaria transmission foci for elimination using human mobility data. PLoS Computational Biology, 12(4):e1004846.

[8].   Global Fund, 2016, Standard Concept Note; Investing for impact against HIV, tuberculosis or Malaria, 2016 to 2019.

[9].   Snow, R. W., Amratia, P., Kabaria, C. W., Noor, A. M., Marsh, K., 2012, The changing limits and incidence of Malaria in Africa: 1939–2009. In Advances in Parasitology, 78:169–262. Academic Press.

[10].  Shafiee, S., Topal, E., 2010, An overview of global gold market and gold price forecasting. Resources Policy, 35(3):178–189.

[11].  Broom, M., Rychtář, J., Spears-Gill, T., 2016, The Game-Theoretical Model of Using Insecticide-Treated Bed-Nets to Fight Malaria. Applied Mathematics, 7(9):852–860.

[12].  Katureebe, A., Zinszer, K., Arinaitwe, E., Rek, J., Kakande, E., Charland, K., et al., 2016, Measures of Malaria Burden after Long-Lasting Insecticidal Net Distribution and Indoor Residual Spraying at Three Sites in Uganda: A Prospective Observational Study. PLOS ONE. [cited 2018 Dec 4]. Available from: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002167.

[13].  Yukich, J. O., Zerom, M., Ghebremeskel, T., Tediosi, F., Lengeler, C., 2009, Costs and cost-effectiveness of vector control in Eritrea using insecticide-treated bed nets. Malaria Journal, 8(1):51.

[14].  Yukich, J. O., Zerom, M., Ghebremeskel, T., Tediosi, F., Lengeler, C., 2009, Costs and cost-effectiveness of vector control in Eritrea using insecticide-treated bed nets. Malaria Journal, 8(1):51.

[15].  Uzochukwu, B. S., Obikeze, E. N., Onwujekwe, O. E., Onoka, C. A., Griffiths, U. K., 2009, Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of Malaria in Nigeria: implications for scaling-up deployment of ACT. Malaria Journal, 8(1):265.

[16].  Ansah, E. K., Epokor, M., Whitty, C., Yeung, S., Hansen, K. S., 2013, Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana. The American Journal of Tropical Medicine and Hygiene, 89(4):724–736. https://doi.org/10.4269/ajtmh.13-0033.

[17].  Hansen, K. S., Ndyomugyenyi, R., Magnussen, P., Lal, S., Clarke, S. E., 2017, Cost-effectiveness analysis of Malaria rapid diagnostic tests for appropriate treatment of Malaria at the community level in Uganda. Health Policy and Planning, 32(5):676–689. https://doi.org/10.1093/heapol/czw171.

[18].  Batwala, V., Magnussen, P., Hansen, K. S., et al., 2011, Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malaria Journal, 10:372. https://doi.org/10.1186/1475-2875-10-372.

[19].  Guyana Ministry of Health, Coordination with stakeholders in the Malaria affected regions. Pilot project: Operationalization of the malaria strategy in Region 8 – Potaro-Siparuni, Guyana.

[20].  Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., et al., 2013, Consolidated Health Economic Evaluation Reporting Standards [CHEERS]—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value in Health, 16(2):231–250.